http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-30867-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 2008-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_451259b5350cabf29378b181d0dee7ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fc03a1a288f6f4ed91934938fa046dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc472def426d6162898b9d6471590438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_decf8ee2f1a43402f5d9e47d58c0622d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b09f0d7d671dba1cc6a5e65dd7b18a8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d65b74bc33601c4a115680710a2b5038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58a740152231dfa7b05772e802ee3580
publicationDate 2008-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-30867-A1
titleOfInvention NEW ANALOGS OF PIRIDINA VII 543
abstract The present invention relates to certain new pyridine analogs of formula (I) to processes for preparing said compounds, to their usefulness as inhibitors of P2Y12 and as antithrombotic agents, etc., their use as medicaments in cardiovascular diseases, as well as to pharmaceutical compositions that contain them.
priorityDate 2007-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992

Total number of triples: 30.